Norwegian Medical Products Agency
Appearance
This article needs additional citations for verification. (November 2023) |
The Norwegian Medical Products Agency formerly the Norwegian Medicines Agency (Direktoratet for Medisinske Produkter tidl. Statens legemiddelverk, Legemiddelverket) is the national regulatory authority in Norway for new and existing pharmaceuticals, medical devices and for the supply chain security of these. The Agency is responsible for supervising the production, trials and marketing of medicines. It approves medicines and monitors their use, and ensures cost-efficient, effective and well-documented use of medicines. The Inspectorate also supervises the supply chain and regulates pharmacy prices and trade conditions.[1]
References
[edit]- ^ "Our goals and tasks". Norwegian Medical Products Agency. Archived from the original on 2024-12-12. Retrieved 2024-12-13.